PAPER Zheng X, Wang S, Huang J, Li C, Shang H
SEARCH RESULTS
330637 RESULTS
PAPER Castro-Gomez S, Heneka MT
Innate immune activation in neurodegenerative diseases.
Immunity. 2024 Apr 9;57(4):790-814. PubMed: 38599171PAPER Meissner WG, Remy P, Giordana C, Maltête D, Derkinderen P, Houéto JL, Anheim M, Benatru I, Boraud T, Brefel-Courbon C, Carrière N, Catala H, Colin O, Corvol JC, Damier P, Dellapina E, Devos D, Drapier S, Fabbri M, Ferrier V, Foubert-Samier A, Frismand-Kryloff S, Georget A, Germain C, Grimaldi S, Hardy C, Hopes L, Krystkowiak P, Laurens B, Lefaucheur R, Mariani LL, Marques A, Marse C, Ory-Magne F, Rigalleau V, Salhi H, Saubion A, Stott SR, Thalamas C, Thiriez C, Tir M, Wyse RK, Benard A, Rascol O, LIXIPARK Study Group
Trial of Lixisenatide in Early Parkinson's Disease.
N Engl J Med. 2024 Apr 4;390(13):1176-1185. PubMed: 38598572PAPER Ma X, Shyer M, Harris K, Wang D, Hsu YC, Farrell C, Goodwin N, Anjum S, Bukhbinder AS, Dean S, Khan T, Hunter D, Schulz PE, Jiang X, Kim Y
Deep learning to predict rapid progression of Alzheimer's disease from pooled clinical trials: A retrospective study.
PLOS Digit Health. 2024 Apr;3(4):e0000479. Epub 2024 Apr 10 PubMed: 38598464PAPER Pierson SR, Kolling LJ, James TD, Pushpavathi SG, Marcinkiewcz CA
Serotonergic dysfunction may mediate the relationship between alcohol consumption and Alzheimer's disease.
Pharmacol Res. 2024 Apr 9;203:107171. PubMed: 38599469PAPER Simons RL, Ong ML, Lei MK, Beach SR, Zhang Y, Philibert R, Mielke MM
Racial discrimination during middle age predicts higher serum phosphorylated tau and neurofilament light chain levels a decade later: A study of aging black Americans.
Alzheimers Dement. 2024 Apr 10; PubMed: 38597292PAPER Eldeeb MA, Fallahi A, Soumbasis A, Bayne AN, Trempe JF, Fon EA
Mitochondrial import stress and PINK1-mediated mitophagy: the role of the PINK1-TOMM-TIMM23 supercomplex.
Autophagy. 2024 Apr 14;:1-3. PubMed: 38597070PAPER Wang H, Zhou L, Zheng Q, Song Y, Huang W, Yang L, Xiong Y, Cai Z, Chen Y, Yuan J
Kai-xin-san improves cognitive impairment in D-gal and Aβ25-35 induced ad rats by regulating gut microbiota and reducing neuronal damage.
J Ethnopharmacol. 2024 Apr 9;329:118161. PubMed: 38599474PAPER Weber DM, Taylor SW, Lagier RJ, Kim JC, Goldman SM, Clarke NJ, Vaillancourt DE, Duara R, McFarland KN, Wang WE, Golde TE, Racke MK
Clinical utility of plasma Aβ42/40 ratio by LC-MS/MS in Alzheimer's disease assessment.
Front Neurol. 2024;15:1364658. Epub 2024 Mar 25 PubMed: 38595851Multiple Strategies Seek to Banish α-Synuclein Aggregates
RESEARCH NEWS 2024-04-10 Research News For synucleinopathies, which include Parkinson’s disease, multiple system atrophy, and dementia with Lewy bodies, scientists currently have no way to slow the underlying disease progression. Many groups are on the hunt for ways to prevent or
Erica Cristina Nascimento
Postdoc Fellow AssociatedBrasilia, Brazil
Timothy Parker
San Antonio, United States
Wing Ho Chua
PAPER Liu RH, Xiao XY, Yao L, Jia YY, Guo J, Wang XC, Kong Y, Kong QX
Eukaryotic translation initiation factor EIF4G1 p.Ser637Cys mutation in a family with Parkinson's disease with antecedent essential tremor.
Exp Ther Med. 2024 May;27(5):206. Epub 2024 Mar 19 PubMed: 38590578PAPER Baumann K
Modelling tauopathies.
Nat Rev Mol Cell Biol. 2024 Apr 9; PubMed: 38594384Current Filters
- Date Range : All x